obinutuzumab Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression By www.haematologica.org Published On :: 2020-05-01T00:05:42-07:00 Full Article
obinutuzumab Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma By www.haematologica.org Published On :: 2020-05-01T00:05:42-07:00 Full Article
